Related references
Note: Only part of the references are listed.PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot-Marie-Tooth 1A biomarker
Lucilla Nobbio et al.
BRAIN (2014)
PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: Involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways
Alessandro Castorina et al.
EXPERIMENTAL CELL RESEARCH (2014)
Clinical development success rates for investigational drugs
Michael Hay et al.
NATURE BIOTECHNOLOGY (2014)
Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A
Robert Fledrich et al.
NATURE MEDICINE (2014)
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
Shahram Attarian et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
The Need for Randomization in Animal Trials: An Overview of Systematic Reviews
Jennifer A. Hirst et al.
PLOS ONE (2014)
Similarities between Inherited Demyelinating Neuropathies and Wallerian Degeneration An Old Repair Program May Cause Myelin and Axon Perturbation under Non lesion Conditions
Rudolf Martini et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Reversible Folding of Human Peripheral Myelin Protein 22, a Tetraspan Membrane Protein
Jonathan P. Schlebach et al.
BIOCHEMISTRY (2013)
Signals regulating myelination in peripheral nerves and the Schwann cell response to injury
Thomas D. Glenn et al.
CURRENT OPINION IN NEUROBIOLOGY (2013)
Clinical implications of genetic advances in Charcot-Marie-Tooth disease
Alexander M. Rossor et al.
NATURE REVIEWS NEUROLOGY (2013)
A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients
Robert Fledrich et al.
BRAIN (2012)
Molecular mechanisms regulating myelination in the peripheral nervous system
Jorge A. Pereira et al.
TRENDS IN NEUROSCIENCES (2012)
Update on Charcot-Marie-Tooth Disease
Agnes Patzko et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
A new long term in vitro model of myelination
Noelle Callizot et al.
EXPERIMENTAL CELL RESEARCH (2011)
Mouse Schwann Cells Need Both NRG1 and Cyclic AMP to Myelinate
Peter Arthur-Farraj et al.
GLIA (2011)
Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats
Pascal Tetreault et al.
PHYSIOLOGY & BEHAVIOR (2011)
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Carol Kilkenny et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2010)
Role of naturally occurring osmolytes in protein folding and stability
Raj Kumar
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
PMP22 expression in dermal nerve myelin from patients with CMT1A
Istvan Katona et al.
BRAIN (2009)
Axon-glial signaling and the glial support of axon function
Klaus-Armin Nave et al.
ANNUAL REVIEW OF NEUROSCIENCE (2008)
Pharmacological induction of the heat shock response improves myelination in a neuropathic model
Sunitha Rangaraju et al.
NEUROBIOLOGY OF DISEASE (2008)
Neuropathy progression in Charcot-Marie-Tooth disease type 1A
M. E. Shy et al.
NEUROLOGY (2008)
被撤回的出版物: High-Affinity Naloxone Binding to Filamin A Prevents Mu Opioid Receptor-Gs Coupling Underlying Opioid Tolerance and Dependence (Retracted article. See vol. 17, 2022)
Hoau-Yan Wang et al.
PLOS ONE (2008)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Antinociceptive efficacy of lacosamide in rat models for tumor- and chemotherapy-induced cancer pain
Bettina K. Beyreuther et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy
Gerd Meyer zu Horste et al.
ANNALS OF NEUROLOGY (2007)
An overview of drug combination analysis with isobolograms
Ronald J. Tallarida
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
Isobolographic analysis for combinations of a full and partial agonist: Curved isoboles
Y Grabovsky et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination
T Ogata et al.
JOURNAL OF NEUROSCIENCE (2004)
Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
MW Sereda et al.
NATURE MEDICINE (2003)
The neurotrophin receptor p75NTR as a positive modulator of myelination
JM Cosgaya et al.
SCIENCE (2002)
Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies
M Hai et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A
L Nobbio et al.
ANNALS OF NEUROLOGY (2001)
Molecular dissection of the Schwann cell specific promoter of the PMP22 gene
D Sabéran-Djoneidi et al.
GENE (2000)
GABA(B) receptor protein and mRNA distribution in rat spinal cord and dorsal root ganglia
S Towers et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
